Our study found the down-regulation of VEGF at both protein and mRNA levels in NSCLC cells upon lumbrokinase treatment, suggesting the possible role of lumbrokinase in inhibiting tumor angiogenesis, thereby restraining the progression of NSCLC, which has been proven by our in vitro and in vivo study. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.